Penumbra (PEN) Nyanmɛn Kpɛn

Penumbra

Healthcare · USD · United States of America

TG WA X in ⧉

Nɛnɛn kpanlan$318.85Kpɛn 25 Sep 2026 19:59 UTC

Chɛ̀ndʒ-0.29%

AI bɛ́nɛ́nɛ́: PEN

1 jɔ̀rnɛ̀l

$318.85

🔒 Yɛ́lɛ́ Premium

1 sɛ̀mɛ̀n

$318.85

🔒 Yɛ́lɛ́ Premium

1 mɔ̀sɔ̀

$318.85

🔒 Yɛ́lɛ́ Premium

AI bɛ sɔhɛn sɛn na ɛbɛ yɛ a ɛwɔ nna a ɛdi akyi, nnwɔtwe no awieeɛ ne bosome no awieeɛ. Nsakraeɛ no yɛ nea wɔhwɛ firi sika a ɛwɔ hɔ seesei. Eyinom yɛ nkyɛmu nhyehyɛeɛ, ɛnyɛ nkyɛmu a wɔde bɛyɛ adwuma.

Prix su les 6 mois derniers

Premium ɛn nyɛ AI sika tɔnɔw 1 da, 1 kɛsɛli kɛn 1 bɛn fɔlɔ ni sika tɔnɔw a ni ahunye bɛɛ.

Yɛ́lɛ́ Premium

🔒 Nzɛnkan nyinmɛn

Kpɛnɛn nyanmiɛn su lɛlɛ su — kpɛnɛn nyanmiɛn su lɛlɛ kun'n su, su'n su kpɛnɛn su lɛlɛ kun'n su — yɛ Premium su.

Yɛ́lɛ́ Premium

Nyanmiɛn nɛnɛn

Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The company offers devices for the treatment of peripheral vascular and neurovascular conditions, helping patients suffering from stroke and other neurovascular diseases.

Stocks sɛn nyɛ

TXG10X Genomics Inc Nɛnɛn kpanlan$85.71 +1.90%AI bɛ́nɛ́nɛ́ · 1 jɔ̀rnɛ̀l🔒 Premium ABTAbbott Nɛnɛn kpanlan$101.31 +0.24%AI bɛ́nɛ́nɛ́ · 1 jɔ̀rnɛ̀l🔒 Premium ABBVAbbVie Nɛnɛn kpanlan$264.31 -0.31%AI bɛ́nɛ́nɛ́ · 1 jɔ̀rnɛ̀l🔒 Premium ABCLAbCellera Biologics Nɛnɛn kpanlan$12.72 +0.47%AI bɛ́nɛ́nɛ́ · 1 jɔ̀rnɛ̀l🔒 Premium ACADACADIA Pharmaceuticals Inc Nɛnɛn kpanlan$20.68 -6.76%AI bɛ́nɛ́nɛ́ · 1 jɔ̀rnɛ̀l🔒 Premium ACMRACM Research Inc Nɛnɛn kpanlan$77.34 +1.52%AI bɛ́nɛ́nɛ́ · 1 jɔ̀rnɛ̀l🔒 Premium ADAPAdaptimmune Therapeutics АДР Nɛnɛn kpanlan$0.03 +50.00%AI bɛ́nɛ́nɛ́ · 1 jɔ̀rnɛ̀l🔒 Premium ADPTAdaptive Biotechnologies Nɛnɛn kpanlan$29.45 -0.41%AI bɛ́nɛ́nɛ́ · 1 jɔ̀rnɛ̀l🔒 Premium

Sù AI Stock Predictions

Download our app for AI stock forecasts nɛ iPhone, Android anɛ Windows

Yɛ́lɛ́ Premium

Disclaimer: AI-generated stock predictions nɛ a yɛ for informational purposes only anɛ do not constitute financial advice. Past performance does not guarantee future results. Always do your own research anɛ consult a qualified financial advisor before making investment decisions. Investing involves risk, including possible loss of principal.